Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B - Concepedia

Concepedia

Publication | Closed Access

Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B

62

Citations

35

References

2016

Year

Julianne Bayliss, Lilly Yuen, Gillian Rosenberg, Darren Wong, Margaret Littlejohn, Kathleen Jackson, Anuj Gaggar, Kathryn M. Kitrinos, G. Mani Subramanian, Patrick Marcellin,

Abstract

NCT00116805; Post result.

References

	Year	Citations

Page 1